LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
94628-5
|
Mycoplasma bovis DNA
|
ThreshNum
|
Pt
|
XXX
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
Mycoplasma bovis DNA [Cycle Threshold #] in Specimen by NAA with probe detection
|
Mp bovis DNA Ct Spec Qn NAA+probe
| null |
ACTIVE
|
2.68
|
2.69
|
94629-3
|
Mycobacterium avium subspecies paratuberculosis DNA
|
ThreshNum
|
Pt
|
XXX
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
Mycobacterium avium ss paratuberculosis DNA [Cycle Threshold #] in Specimen by NAA with probe detection
|
M avium paraTB DNA Ct Spec Qn NAA+probe
| null |
ACTIVE
|
2.68
|
2.69
|
94630-1
|
Mannheimia haemolytica DNA
|
ThreshNum
|
Pt
|
XXX
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
Mannheimia haemolytica DNA [Cycle Threshold #] in Specimen by NAA with probe detection
|
M haemolytica DNA Ct Spec Qn NAA+probe
| null |
ACTIVE
|
2.68
|
2.69
|
9463-1
|
Arsenic
|
MCnc
|
Pt
|
Water
|
Qn
| null |
DRUG/TOX
| 1 |
Arsenic [Mass/volume] in Water
|
Arsenic Wat-mCnc
| null |
ACTIVE
|
1.0i
|
2.7
|
94631-9
|
Haemophilus somnus DNA
|
ThreshNum
|
Pt
|
XXX
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
Haemophilus somnus DNA [Cycle Threshold #] in Specimen by NAA with probe detection
|
H somnus DNA Ct Spec Qn NAA+probe
| null |
ACTIVE
|
2.68
|
2.69
|
94632-7
|
Escherichia coli K99 DNA
|
ThreshNum
|
Pt
|
XXX
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
Escherichia coli K99 DNA [Cycle Threshold #] in Specimen by NAA with probe detection
|
E coli K99 DNA Ct Spec Qn NAA+probe
| null |
ACTIVE
|
2.68
|
2.69
|
94633-5
|
Cryptosporidium parvum DNA
|
ThreshNum
|
Pt
|
XXX
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
Cryptosporidium parvum DNA [Cycle Threshold #] in Specimen by NAA with probe detection
|
C parvum DNA Ct Spec Qn NAA+probe
| null |
ACTIVE
|
2.68
|
2.69
|
94634-3
|
Coxiella burnetii DNA
|
ThreshNum
|
Pt
|
XXX
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
Coxiella burnetii DNA [Cycle Threshold #] in Specimen by NAA with probe detection
|
C burnet DNA Ct Spec Qn NAA+probe
| null |
ACTIVE
|
2.68
|
2.69
|
94635-0
|
Bovine diarrhea virus RNA
|
ThreshNum
|
Pt
|
XXX
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
Bovine diarrhea virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
|
BVDV RNA Ct Spec Qn NAA+probe
| null |
ACTIVE
|
2.68
|
2.69
|
94636-8
|
Bovine respiratory syncytial virus RNA
|
ThreshNum
|
Pt
|
XXX
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
Bovine respiratory syncytial virus RNA [Cycle Threshold #] in Specimen by NAA with probe detection
|
BRSV RNA Ct Spec Qn NAA+probe
| null |
ACTIVE
|
2.68
|
2.69
|
94637-6
|
Mycobacterium avium subspecies paratuberculosis Ab
|
Titr
|
Pt
|
Ser
|
Qn
|
Comp fix
|
MICRO
| 1 |
Mycobacterium avium ss paratuberculosis Ab [Titer] in Serum by Complement fixation
|
M avium paraTB Ab Titr Ser CF
| null |
ACTIVE
|
2.68
|
2.68
|
94638-4
|
Bovine respiratory syncytial virus Ab.Neut
|
Titr
|
Pt
|
Ser
|
Qn
|
Neut
|
MICRO
| 1 |
Bovine respiratory syncytial virus neutralizing antibody [Titer] in Serum by Neutralization test
|
BRSV NAb Titr Ser Nt
| null |
ACTIVE
|
2.68
|
2.72
|
94639-2
|
SARS coronavirus 2 ORF1ab region
|
PrThr
|
Pt
|
XXX
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Specimen by NAA with probe detection
|
SARS-CoV-2 ORF1ab Spec Ql NAA+probe
| null |
ACTIVE
|
2.68
|
2.69
|
946-4
|
C Ag
|
PrThr
|
Pt
|
RBC^BPU
|
Ord
| null |
BLDBK
| 1 |
C Ag [Presence] on Red Blood Cells from Blood product unit
|
C Ag RBC BPU Ql
| null |
ACTIVE
|
1.0
|
2.73
|
94640-0
|
SARS coronavirus 2 S gene
|
PrThr
|
Pt
|
Respiratory
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
SARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory specimen by NAA with probe detection
|
SARS-CoV-2 S gene Resp Ql NAA+probe
| null |
ACTIVE
|
2.68
|
2.69
|
94641-8
|
SARS coronavirus 2 S gene
|
PrThr
|
Pt
|
XXX
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
SARS-CoV-2 (COVID-19) S gene [Presence] in Specimen by NAA with probe detection
|
SARS-CoV-2 S gene Spec Ql NAA+probe
| null |
ACTIVE
|
2.68
|
2.69
|
94642-6
|
SARS coronavirus 2 S gene
|
ThreshNum
|
Pt
|
Respiratory
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
SARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
|
SARS-CoV-2 S gene Ct Resp Qn NAA+probe
| null |
ACTIVE
|
2.68
|
2.69
|
94643-4
|
SARS coronavirus 2 S gene
|
ThreshNum
|
Pt
|
XXX
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
SARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Specimen by NAA with probe detection
|
SARS-CoV-2 S gene Ct Spec Qn NAA+probe
| null |
ACTIVE
|
2.68
|
2.69
|
94644-2
|
SARS coronavirus 2 ORF1ab region
|
ThreshNum
|
Pt
|
Respiratory
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
SARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
|
SARS-CoV-2 ORF1ab Ct Resp Qn NAA+probe
| null |
ACTIVE
|
2.68
|
2.69
|
94645-9
|
SARS coronavirus 2 RdRp gene
|
ThreshNum
|
Pt
|
XXX
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
SARS-CoV-2 (COVID-19) RdRp gene [Cycle Threshold #] in Specimen by NAA with probe detection
|
SARS-CoV-2 RdRp Ct Spec Qn NAA+probe
| null |
ACTIVE
|
2.68
|
2.69
|
94646-7
|
SARS coronavirus 2 RdRp gene
|
ThreshNum
|
Pt
|
Respiratory
|
Qn
|
Probe.amp.tar
|
MICRO
| 1 |
SARS-CoV-2 (COVID-19) RdRp gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
|
SARS-CoV-2 RdRp Ct Resp Qn NAA+probe
| null |
ACTIVE
|
2.68
|
2.69
|
94647-5
|
SARS-related coronavirus RNA
|
PrThr
|
Pt
|
XXX
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
SARS-related coronavirus RNA [Presence] in Specimen by NAA with probe detection
|
SARSr-CoV RNA Spec Ql NAA+probe
| null |
ACTIVE
|
2.68
|
2.69
|
94648-3
|
Date of case confirmation
|
Date
|
Pt
|
^Contact
|
Qn
| null |
PUBLICHEALTH
| 2 |
Date contact confirmed as a case
|
Date contact confirmed as case
| null |
ACTIVE
|
2.68
|
2.68
|
9464-9
|
Barium
|
MCnc
|
Pt
|
Water
|
Qn
| null |
DRUG/TOX
| 1 |
Barium [Mass/volume] in Water
|
Barium Wat-mCnc
| null |
ACTIVE
|
1.0i
|
2.7
|
94649-1
|
Health department
|
ID
|
Pt
|
Organization
|
Nom
| null |
ADMIN.FACILITY
| 2 |
Health department identifier
|
Health dept ID
| null |
ACTIVE
|
2.68
|
2.68
|
94650-9
|
Contact identifier
|
ID
|
Pt
|
^Contact
|
Nom
| null |
ADMIN.ID
| 2 |
Contact identifier Contact
|
Contact ID Contact
| null |
ACTIVE
|
2.68
|
2.68
|
94651-7
|
Country of travel
|
Loc
|
Pt
|
^Patient
|
Nom
| null |
H&P.HX
| 2 |
Country of travel [Location]
|
Country of trav
| null |
ACTIVE
|
2.68
|
2.68
|
94652-5
|
Known exposure date
|
Date
|
Pt
|
^Patient
|
Qn
| null |
H&P.HX
| 2 |
Known exposure date
|
Exposure date
| null |
ACTIVE
|
2.68
|
2.68
|
94653-3
|
City of travel
|
Loc
|
Pt
|
^Patient
|
Nom
| null |
H&P.HX
| 2 |
City of travel [Location]
|
City of trav
| null |
ACTIVE
|
2.68
|
2.68
|
94654-1
|
Known exposure panel
|
-
|
Pt
|
^Patient
|
-
| null |
PANEL.H&P
| 2 |
Known exposure panel
|
Exposure pnl
| null |
ACTIVE
|
2.68
|
2.68
|
94655-8
|
Identifier & Assigning authority panel
|
-
|
Pt
|
^Patient
|
-
| null |
PANEL.ADMIN
| 2 |
Identifier and Assigning authority panel
|
ID & Authority panel
| null |
ACTIVE
|
2.68
|
2.68
|
9465-6
|
Benzene
|
MCnc
|
Pt
|
Urine
|
Qn
| null |
DRUG/TOX
| 1 |
Benzene [Mass/volume] in Urine
|
Benzene Ur-mCnc
| null |
ACTIVE
|
1.0i
|
2.73
|
94656-6
|
State of known exposure
|
Loc
|
Pt
|
^Patient
|
Nom
| null |
H&P.HX
| 2 |
State of known exposure
|
State of exposure
| null |
ACTIVE
|
2.68
|
2.68
|
94657-4
|
Case identifier
|
ID
|
Pt
|
^Contact
|
Nom
| null |
ADMIN
| 2 |
Contact case identifier
|
Case ID Contact
| null |
ACTIVE
|
2.68
|
2.68
|
94658-2
|
City of known exposure
|
Loc
|
Pt
|
^Patient
|
Nom
| null |
H&P.HX
| 2 |
City of known exposure
|
City of exposure
| null |
ACTIVE
|
2.68
|
2.68
|
94659-0
|
Case identifier
|
ID
|
Pt
|
^Patient
|
Nom
| null |
ADMIN
| 2 |
Case identifier
|
Case ID
| null |
ACTIVE
|
2.68
|
2.68
|
94660-8
|
SARS coronavirus 2 RNA
|
PrThr
|
Pt
|
Ser/Plas
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
SARS-CoV-2 (COVID-19) RNA [Presence] in Serum or Plasma by NAA with probe detection
|
SARS-CoV-2 RNA SerPl Ql NAA+probe
| null |
ACTIVE
|
2.68
|
2.69
|
94661-6
|
SARS coronavirus 2 Ab
|
Imp
|
Pt
|
Ser/Plas
|
Nom
| null |
MICRO
| 1 |
SARS-CoV-2 (COVID-19) Ab [Interpretation] in Serum or Plasma
|
SARS-CoV-2 Ab SerPl-Imp
| null |
ACTIVE
|
2.68
|
2.69
|
94662-4
|
Coccidioides immitis Ab.IgG
|
PrThr
|
Pt
|
CSF
|
Ord
|
Immune diffusion
|
MICRO
| 1 |
Coccidioides immitis IgG Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID)
|
C immitis IgG CSF Ql ID
| null |
ACTIVE
|
2.68
|
2.68
|
94663-2
|
Coccidioides immitis Ab.IgM
|
PrThr
|
Pt
|
CSF
|
Ord
|
Immune diffusion
|
MICRO
| 1 |
Coccidioides immitis IgM Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID)
|
C immitis IgM CSF Ql ID
| null |
ACTIVE
|
2.68
|
2.68
|
9466-4
|
Cadmium
|
MCnc
|
Pt
|
Water
|
Qn
| null |
DRUG/TOX
| 1 |
Cadmium [Mass/volume] in Water
|
Cadmium Wat-mCnc
| null |
ACTIVE
|
1.0i
|
2.7
|
94664-0
|
Anticipated discharge date
|
Date
|
Pt
|
^Patient
|
Qn
| null |
H&P.HX
| 2 |
Anticipated discharge date
|
Anticipated discharge date
| null |
ACTIVE
|
2.68
|
2.68
|
94665-7
|
Granulomatous prostatitis
|
PrThr
|
Pt
|
Specimen
|
Ord
|
Microscopy
|
PATH
| 1 |
Granulomatous prostatitis [Presence] in Specimen by Microscopy
|
Granulomatous prostatitis Spec Ql Micro
| null |
ACTIVE
|
2.68
|
2.68
|
94666-5
|
High grade prostatic intraepithelial neoplasia
|
PrThr
|
Pt
|
Specimen
|
Ord
|
Microscopy
|
PATH
| 1 |
High grade prostatic intraepithelial neoplasia [Presence] in Specimen by Microscopy
|
HGPIN Spec Ql Micro
| null |
ACTIVE
|
2.68
|
2.68
|
94667-3
|
Delayed hypersensitivity anergy panel
|
-
|
Pt
|
Skin
|
-
| null |
PANEL.CHAL
| 1 |
Delayed hypersensitivity anergy intradermal panel
|
DTH Anergy Pnl Skin
| null |
ACTIVE
|
2.68
|
2.68
|
94668-1
|
Reaction wheal^1D post control ID
|
Diam
|
Pt
|
Skin
|
Qn
| null |
CHALSKIN
| 1 |
Reaction wheal [Diameter] --1 day post dose control intradermal
|
Rx wheal 1D p control ID Diam
| null |
ACTIVE
|
2.68
|
2.68
|
94669-9
|
Reaction wheal^2D post control ID
|
Diam
|
Pt
|
Skin
|
Qn
| null |
CHALSKIN
| 1 |
Reaction wheal [Diameter] --2 day post dose control intradermal
|
Rx wheal 2D p control ID Diam
| null |
ACTIVE
|
2.68
|
2.68
|
94670-7
|
Tetanus reaction wheal^1D post tetanus toxoid ID
|
Diam
|
Pt
|
Skin
|
Qn
| null |
CHALSKIN
| 1 |
Tetanus reaction wheal [Diameter] --1 day post tetanus toxoid intradermal
|
Tetanus Rx 1D p tet tox ID Diam
| null |
ACTIVE
|
2.68
|
2.68
|
94671-5
|
Tetanus reaction wheal^2D post tetanus toxoid ID
|
Diam
|
Pt
|
Skin
|
Qn
| null |
CHALSKIN
| 1 |
Tetanus reaction wheal [Diameter] --2 day post tetanus toxoid intradermal
|
Tetanus Rx 2D p tet tox ID Diam
| null |
ACTIVE
|
2.68
|
2.68
|
9467-2
|
Calcium
|
MCnc
|
Pt
|
Water
|
Qn
| null |
CHEM
| 1 |
Calcium [Mass/volume] in Water
|
Calcium Wat-mCnc
| null |
ACTIVE
|
1.0i
|
2.7
|
94672-3
|
24r-Hydroxycalcidiol+24r-Hydroxyercalcidiol
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
CHEM
| 1 |
24,25-dihydroxyvitamin D3+24,25-dihydroxyvitamin D2 [Mass/volume] in Serum or Plasma
|
24,25(OH)2 VitD SerPl-mCnc
| null |
ACTIVE
|
2.68
|
2.68
|
94673-1
|
Calcidiol+ercalcidiol/24r-Hydroxycalcidiol+24r-Hydroxyercalcidiol
|
MRto
|
Pt
|
Ser/Plas
|
Qn
| null |
CHEM
| 1 |
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2/24,25-dihydroxyvitamin D3+24,25-dihydroxyvitamin D2 [Mass Ratio] in Serum or Plasma
|
25(OH)D3+25(OH)D2/24,25(OH)2 VitD SerPl
| null |
ACTIVE
|
2.68
|
2.68
|
94674-9
|
Calcidiol+ercalcidiol/24r-Hydroxycalcidiol+24r-Hydroxyercalcidiol ratio panel
|
-
|
Pt
|
Ser/Plas
|
-
| null |
PANEL.CHEM
| 1 |
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2/24,25-dihydroxyvitamin D3+24,25-dihydroxyvitamin D2 ratio panel in Serum or Plasma
|
25D3+25D2/24,25D3+24,25D2 Pnl SerPl
| null |
ACTIVE
|
2.68
|
2.68
|
94675-6
|
Dipeptidyl aminopeptidase-like protein 6 Ab.IgG
|
Titr
|
Pt
|
Ser
|
Qn
|
IF
|
SERO
| 1 |
Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Titer] in Serum by Immunofluorescence
|
DPPX IgG Titr Ser IF
| null |
ACTIVE
|
2.68
|
2.68
|
94676-4
|
Dipeptidyl aminopeptidase-like protein 6 Ab.IgG
|
PrThr
|
Pt
|
Ser
|
Ord
|
CBA IFA
|
SERO
| 1 |
Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
|
DPPX IgG Ser Ql CBA IFA
| null |
ACTIVE
|
2.68
|
2.69
|
94677-2
|
Glomerular filtration rate/1.73 sq M.predicted
|
ArVRat
|
Pt
|
Ser/Plas/Bld
|
Qn
|
Creatinine and Cystatin C-based formula (CKD-EPI)
|
CHEM
| 1 |
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine and Cystatin C-based formula (CKD-EPI)
|
GFR/BSA.pred SerPlBld Creat+Cyst CKD-EPI
| null |
ACTIVE
|
2.68
|
2.72
|
94678-0
|
Views for patency^W radionuclide IV
|
Find
|
Pt
|
Abdomen>Liver+Biliary ducts+Gallbladder
|
Doc
|
NM
|
RAD
| 2 |
NM Liver and Biliary ducts and Gallbladder Views for patency
|
NM Liver+BDs+GB Views for pat W RNC IV
| null |
ACTIVE
|
2.68
|
2.69
|
94679-8
|
View && Views supine + upright + lateral-decubitus
|
Find
|
Pt
|
Chest && Abdomen
|
Doc
|
XR
|
RAD
| 2 |
XR Chest Single View and Abdomen Supine and Upright and Lateral-decubitus
|
XR Chest 1V + Abd Sup+Upr+Lat-Decub
| null |
ACTIVE
|
2.68
|
2.69
|
9468-0
|
Chloramines
|
MCnc
|
Pt
|
Water
|
Qn
| null |
DRUG/TOX
| 1 |
Chloramines [Mass/volume] in Water
|
Chloramines Wat-mCnc
| null |
ACTIVE
|
1.0i
|
2.7
|
94680-6
|
Multisection limited
|
Find
|
Pt
|
Chest>Aorta.thoracic & Abdomen>Aorta.abdominal+Vena cava.inferior & Abdomen+Pelvis>Iliac vessels
|
Doc
|
US.doppler
|
RAD
| 2 |
US.doppler Thoracic and Abdominal Aorta and Inferior Vena Cava and Illiac vessels limited
|
DOP T Ao+Abd Ao+IVC+Ves-Il Ltd
| null |
ACTIVE
|
2.68
|
2.69
|
94681-4
|
Multisection
|
Find
|
Pt
|
Chest>Aorta.thoracic & Abdomen>Aorta.abdominal+Vena cava.inferior & Abdomen+Pelvis>Iliac vessels
|
Doc
|
US.doppler
|
RAD
| 2 |
US.doppler Thoracic and Abdominal Aorta and Inferior Vena Cava and Illiac vessels
|
DOP T Ao+Abd Ao+IVC+Ves-Il
| null |
ACTIVE
|
2.68
|
2.69
|
94682-2
|
Views GE 2
|
Find
|
Pt
|
Lower extremity>Calcaneus
|
Doc
|
XR
|
RAD
| 2 |
XR Calcaneus GE 2 Views
|
XR Heel GE 2V
| null |
ACTIVE
|
2.68
|
2.69
|
94683-0
|
Views GE 2
|
Find
|
Pt
|
Pelvis & Lower extremity.unilateral>Hip
|
Doc
|
XR
|
RAD
| 2 |
XR Pelvis and Hip - unilateral GE 2 Views
|
XR Pelvis and Hip-Ul GE 2V
| null |
ACTIVE
|
2.68
|
2.69
|
94684-8
|
Views GE 6^W R-bending + W L-bending
|
Find
|
Pt
|
Abdomen>Spine.lumbar & Pelvis>Sacrum
|
Doc
|
XR
|
RAD
| 2 |
XR Spine Lumbar and Sacrum GE 6 Views W right bending and W left bending
|
XR L-spine+Sacrum GE 6V W R+L-bending
| null |
ACTIVE
|
2.68
|
2.69
|
94685-5
|
Views GE 3 && view PA
|
Find
|
Pt
|
Chest>Ribs.unilateral && Chest
|
Doc
|
XR
|
RAD
| 2 |
XR Ribs - unilateral GE 3 Views and Chest PA
|
XR Ribs-Ul GE 3V + Chest PA
| null |
ACTIVE
|
2.68
|
2.69
|
94686-3
|
Multisection^WO & W contrast IV && Multisection^WO contrast
|
Find
|
Pt
|
Head>Brain && Head>Head vessels
|
Doc
|
MR && MR.angio
|
RAD
| 2 |
MR Brain WO and W contrast IV and MRA Brain WO contrast
|
MR Brain WO+W contr IV+MRA WO contr
| null |
ACTIVE
|
2.68
|
2.69
|
94687-1
|
Multisection^WO contrast
|
Find
|
Pt
|
Abdomen>Abdominal vessels & Pelvis>Pelvis vessels
|
Doc
|
CT.angio
|
RAD
| 2 |
CTA Abdominal vessels and Pelvis vessels WO contrast
|
CTA Abd ves+Pelvis ves WO contr
| null |
ACTIVE
|
2.68
|
2.69
|
94688-9
|
Multisection^WO & W contrast IV
|
Find
|
Pt
|
Neck>Neck vessels & Chest>Chest vessels
|
Doc
|
CT.angio
|
RAD
| 2 |
CTA Neck vessels and Chest vessels WO and W contrast IV
|
CTA Neck+Chest Ves WO+W contr IV
| null |
ACTIVE
|
2.68
|
2.69
|
94689-7
|
Cells.CD20/100 cells.CD19
|
NFr
|
Pt
|
Bld
|
Qn
| null |
CELLMARK
| 1 |
CD20 cells/100 CD19 cells in Blood
|
CD20 Cells/100 CD19 cells NFr Bld
| null |
ACTIVE
|
2.68
|
2.73
|
94690-5
|
Chondroitin-6-sulfate/Creatinine
|
Ratio
|
Pt
|
Urine
|
Qn
| null |
CHEM
| 1 |
Chondroitin-6-sulfate/Creatinine [Ratio] in Urine
|
C6S/Creat Ur-Rto
| null |
ACTIVE
|
2.68
|
2.68
|
94691-3
|
Dermatan sulfate & heparan sulfate & chondroitin-6-sulfate & keratan sulfate panel
|
-
|
Pt
|
Urine
|
Qn
| null |
PANEL.CHEM
| 1 |
Dermatan sulfate, heparan sulfate, chondroitin-6-sulfate, keratan sulfate panel - Urine
|
MPS panel Ur
| null |
ACTIVE
|
2.68
|
2.68
|
94692-1
|
Dermatan sulfate/Creatinine
|
Ratio
|
Pt
|
Urine
|
Qn
| null |
CHEM
| 1 |
Dermatan sulfate/Creatinine [Ratio] in Urine
|
Dermatan Sulfate/Creat Ur-Rto
| null |
ACTIVE
|
2.68
|
2.68
|
94693-9
|
Heparan sulfate/Creatinine
|
Ratio
|
Pt
|
Urine
|
Qn
| null |
CHEM
| 1 |
Heparan sulfate/Creatinine [Ratio] in Urine
|
Heparan sulfate/Creat Ur-Rto
| null |
ACTIVE
|
2.68
|
2.73
|
94694-7
|
Acetylcholine receptor ganglionic neuronal Ab
|
SCnc
|
Pt
|
Ser
|
Qn
|
IA
|
SERO
| 1 |
Acetylcholine receptor ganglionic neuronal Ab [Moles/volume] in Serum by Immunoassay
|
nAChR Ab Ser IA-sCnc
| null |
ACTIVE
|
2.68
|
2.68
|
94695-4
|
Axonal autoimmune Ab panel
|
-
|
Pt
|
Ser/Plas
|
-
| null |
PANEL.SERO
| 1 |
Axonal autoimmune Ab panel - Serum or Plasma
|
Axonal autoimmune Ab pnl SerPl
| null |
ACTIVE
|
2.68
|
2.68
|
94696-2
|
Dementia autoimmune Ab panel
|
-
|
Pt
|
Ser/Plas
|
-
| null |
PANEL.SERO
| 1 |
Dementia autoimmune Ab panel - Serum or Plasma
|
Dementia autoimmune Ab pnl SerPl
| null |
ACTIVE
|
2.68
|
2.68
|
94697-0
|
Encephalopathy autoimmune Ab panel
|
-
|
Pt
|
Ser/Plas
|
-
| null |
PANEL.SERO
| 1 |
Encephalopathy autoimmune Ab panel - Serum or Plasma
|
Encephalopathy autoimmune Ab pnl SerPl
| null |
ACTIVE
|
2.68
|
2.68
|
9469-8
|
Chromium
|
MCnc
|
Pt
|
Water
|
Qn
| null |
DRUG/TOX
| 1 |
Chromium [Mass/volume] in Water
|
Chromium Wat-mCnc
| null |
ACTIVE
|
1.0i
|
2.7
|
94698-8
|
Epilepsy autoimmune Ab panel
|
-
|
Pt
|
Ser/Plas
|
-
| null |
PANEL.SERO
| 1 |
Epilepsy autoimmune Ab panel - Serum or Plasma
|
Epilepsy autoimmune Ab pnl SerPl
| null |
ACTIVE
|
2.68
|
2.68
|
94699-6
|
Glutamate decarboxylase 65 Ab
|
SCnc
|
Pt
|
Ser
|
Qn
|
IA
|
SERO
| 1 |
Glutamate decarboxylase 65 Ab [Moles/volume] in Serum by Immunoassay
|
GAD65 Ab Ser IA-sCnc
| null |
ACTIVE
|
2.68
|
2.68
|
94700-2
|
Liver diseases autoimmune Ab panel
|
-
|
Pt
|
Ser/Plas
|
-
| null |
PANEL.SERO
| 1 |
Liver diseases autoimmune Ab panel - Serum or Plasma
|
Liver diseases autoimmune Ab pnl SerPl
| null |
ACTIVE
|
2.68
|
2.68
|
94701-0
|
Movement disorder autoimmune Ab panel
|
-
|
Pt
|
Ser/Plas
|
-
| null |
PANEL.SERO
| 1 |
Movement disorder autoimmune Ab panel - Serum or Plasma
|
Movement autoimmune Ab pnl SerPl
| null |
ACTIVE
|
2.68
|
2.68
|
94702-8
|
Purkinje cell cytoplasmic type 1 Ab
|
Titr
|
Pt
|
Ser
|
Qn
|
IF
|
SERO
| 1 |
PCA-1 Ab [Titer] in Serum by Immunofluorescence
|
PCA-1 Ab Titr Ser IF
| null |
ACTIVE
|
2.68
|
2.68
|
94703-6
|
Purkinje cell cytoplasmic type 2 Ab
|
Titr
|
Pt
|
Ser
|
Qn
|
IF
|
SERO
| 1 |
PCA-2 Ab [Titer] in Serum by Immunofluorescence
|
PCA-2 Ab Titr Ser IF
| null |
ACTIVE
|
2.68
|
2.68
|
94704-4
|
Voltage-gated calcium channel N type binding Ab
|
SCnc
|
Pt
|
Ser
|
Qn
|
IA
|
SERO
| 1 |
Voltage-gated calcium channel N type binding Ab [Moles/volume] in Serum by Immunoassay
|
VGCC-N Bind Ab Ser IA-sCnc
| null |
ACTIVE
|
2.68
|
2.68
|
94705-1
|
Voltage-gated calcium channel PQ type binding Ab
|
SCnc
|
Pt
|
Ser
|
Qn
|
IA
|
SERO
| 1 |
Voltage-gated calcium channel P/Q type binding Ab [Moles/volume] in Serum by Immunoassay
|
VGCC-P/Q Bind Ab Ser IA-sCnc
| null |
ACTIVE
|
2.68
|
2.68
|
9470-6
|
Copper
|
MCnc
|
Pt
|
Water
|
Qn
| null |
DRUG/TOX
| 1 |
Copper [Mass/volume] in Water
|
Copper Wat-mCnc
| null |
ACTIVE
|
1.0i
|
2.7
|
94706-9
|
CV2 Ab.IgG
|
Titr
|
Pt
|
CSF
|
Qn
|
IF
|
SERO
| 1 |
CV2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
|
CV2 IgG Titr CSF IF
| null |
ACTIVE
|
2.68
|
2.68
|
94707-7
|
Dementia autoimmune Ab panel
|
-
|
Pt
|
CSF
|
-
| null |
PANEL.SERO
| 1 |
Dementia autoimmune Ab panel - Cerebral spinal fluid
|
Dementia autoimmune Ab pnl CSF
| null |
ACTIVE
|
2.68
|
2.68
|
94708-5
|
Encephalopathy autoimmune Ab panel
|
-
|
Pt
|
CSF
|
-
| null |
PANEL.SERO
| 1 |
Encephalopathy autoimmune Ab panel - Cerebral spinal fluid
|
Encephalopathy autoimmune Ab pnl CSF
| null |
ACTIVE
|
2.68
|
2.68
|
94709-3
|
Epilepsy autoimmune Ab panel
|
-
|
Pt
|
CSF
|
-
| null |
PANEL.SERO
| 1 |
Epilepsy autoimmune Ab panel - Cerebral spinal fluid
|
Epilepsy autoimmune Ab pnl CSF
| null |
ACTIVE
|
2.68
|
2.68
|
94711-9
|
Glutamate decarboxylase 65 Ab
|
SCnc
|
Pt
|
CSF
|
Qn
|
IA
|
SERO
| 1 |
Glutamate decarboxylase 65 Ab [Moles/volume] in Cerebral spinal fluid by Immunoassay
|
GAD65 Ab CSF IA-sCnc
| null |
ACTIVE
|
2.68
|
2.68
|
94712-7
|
Movement disorder autoimmune Ab panel
|
-
|
Pt
|
CSF
|
-
| null |
PANEL.SERO
| 1 |
Movement disorder autoimmune Ab panel - Cerebral spinal fluid
|
Movement autoimmune Ab pnl CSF
| null |
ACTIVE
|
2.68
|
2.68
|
94713-5
|
Aspartylglycosamine
|
SCnc
|
Pt
|
CSF
|
Qn
| null |
CHEM
| 1 |
Aspartylglycosamine [Moles/volume] in Cerebral spinal fluid
|
Aspartylglycosamine CSF-sCnc
| null |
ACTIVE
|
2.68
|
2.68
|
9471-4
|
Fluoride
|
MCnc
|
Pt
|
Water
|
Qn
| null |
DRUG/TOX
| 1 |
Fluoride [Mass/volume] in Water
|
Fluoride Wat-mCnc
| null |
ACTIVE
|
1.0i
|
2.7
|
94714-3
|
Beta globulin
|
MRat
|
24H
|
Urine
|
Qn
|
Electrophoresis
|
CHEM
| 1 |
Beta globulin [Mass/time] in 24 hour Urine by Electrophoresis
|
B-Globulin 24h Ur Elph-mRate
| null |
ACTIVE
|
2.68
|
2.68
|
94715-0
|
Gamma globulin
|
MRat
|
24H
|
Urine
|
Qn
|
Electrophoresis
|
CHEM
| 1 |
Gamma globulin [Mass/time] in 24 hour Urine by Electrophoresis
|
Gamma glob 24h Ur Elph-mRate
| null |
ACTIVE
|
2.68
|
2.68
|
94716-8
|
AGTR1 gene.c.1166A>C
|
Geno
|
Pt
|
Bld
|
Nom
|
Molgen
|
MOLPATH.MUT
| 1 |
AGTR1 gene c.1166A>C [Genotype] in Blood by Molecular genetics method Nominal
|
AGTR1 c.1166A>C Geno Bld
| null |
ACTIVE
|
2.68
|
2.68
|
94717-6
|
SLC25A15 gene.c.562_564delTTC
|
Geno
|
Pt
|
Bld/Tiss
|
Nom
|
Molgen
|
MOLPATH.MUT
| 1 |
SLC25A15 gene c.562_564delTTC [Genotype] in Blood or Tissue by Molecular genetics method Nominal
|
SLC25A15 c.562_564delTTC Geno Bld/T
| null |
ACTIVE
|
2.68
|
2.68
|
94718-4
|
Alpha defensins 1+2+3
|
PrThr
|
Pt
|
Synv fld
|
Ord
|
IA
|
CHEM
| 1 |
Alpha defensins 1+2+3 [Presence] in Synovial fluid by Immunoassay
|
Alpha defensins 1+2+3 Snv Ql IA
| null |
ACTIVE
|
2.68
|
2.72
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.